Two long-term clinical trials and an ongoing international patient registry continue to demonstrate successful control of abnormal acid in the esophagus and significant improvement in patient quality of life through up to four years of follow-up with an excellent safety profile.
Founders
Bevil J. Hogg
Company Description
EndoStim is a medical device company developing therapeutics for gastrointestinal and urological neuro-muscular disorders.